−0.043 EUR
−1.43 M EUR
259.16 K EUR
19.77 M
About INNO-GENE
Sector
CEO
Jacek Wojciechowicz
Website
Headquarters
Poznan
Founded
2010
ISIN
PLINNGN00015
FIGI
BBG010SX3RN7
HyEnergy SA engages in the management of startup biotechnology companies. It also produces and distributes diagnostic products. The company was founded by Michal Kaszuba and Jacek Wojciechowicz in June 2010 and is headquartered in Poznan, Poland.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange INNO-GENE SA ZY -,10 stocks are traded under the ticker WQ3.
Yes, you can track INNO-GENE SA ZY -,10 financials in yearly and quarterly reports right on TradingView.
WQ3 net income for the last quarter is −76.04 K EUR, while the quarter before that showed −98.20 K EUR of net income which accounts for 22.57% change. Track more INNO-GENE SA ZY -,10 financial stats to get the full picture.
No, WQ3 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 27, 2024, the company has 10.00 employees. See our rating of the largest employees — is INNO-GENE SA ZY -,10 on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. INNO-GENE SA ZY -,10 EBITDA is −457.74 K EUR, and current EBITDA margin is −254.17%. See more stats in INNO-GENE SA ZY -,10 financial statements.
Like other stocks, WQ3 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade INNO-GENE SA ZY -,10 stock right from TradingView charts — choose your broker and connect to your account.